Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients

Bone Marrow Transplantation

Volumn 22, Issue 1, 1998, Pages 67-71

  Hammarstrom V ^a   Pauksen, K ^b   Bjorkstrand B ^a   Simonsson, B ^b   Oberg G ^b   Ljungman, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Marrow stem cell transplantation; Tetanus immunity

Indexed keywords

TETANUS ANTIBODY; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; IMMUNE STATUS; LEUKEMIA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEROLOGY; STEM CELL TRANSPLANTATION; TETANUS; TETANUS PROPHYLAXIS;

EID: 0031849993     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701289     Document Type: Article

References (37)

1. Veronesi R. Epidemiology of tetanus. In: L Eckmann (ed). Principles of Tetanus Hans Huber: Bern, 1967, pp 43-48.
2. Bytchenko B. Tetanus as a world problem. In: Eckman L (ed). Principles of Tetanus. Hans Huber: Bern, 1967, pp 21-41.
3. Eckman L. Active and passive tetanus immunization. New Engl J Med 1964; 271: 1087-1091.
4. Galazka AM. The immunological basis for immunization. Module 3: tetanus. In: Expanded Programme on Immunization. World Health Organization: Geneva, 1993.
5. Eckman L. Tetanus: Prophylaxis and Therapy. Grune & Straton: New York, 1963, pp 50-53.
6. Christenson B, Böttiger M. Epidemiology of tetanus in Sweden. Scand J Infect Dis 1987; 19: 1429-1435.
7. Anderson EL, Belshe RB, Bartram J. Differencies in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. J Infect Dis 1988; 157: 731-737.
8. Barkin RM, Samuelson JS, Gotlin LP. DTP reactions and serologic response with reduced dose schedule. J Pediatr 1984; 105: 189-194.
9. Pichichero ME, Barkin RM, Samuelson S. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the booster following the diphtheria and tetanus toxoid vaccine primary series. Ped Inf Dis J 1986; 5: 428-430.
10. Barkin RM, Samuelson JS, Gotlin LP. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule. Dev Biol Stand 1985; 61: 297-307.
11. Simonsen O, Badsberg JH, Kjelsdsen K et al. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand 1986; 94: 77-82.
12. Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Inf Dis 1988; 20: 177-185.
13. Simonsen O, Bentzon MW, Kjeldsen K et al. Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine 1987; 5: 115-122.
14. Galazka A, Sporzynska Z. Immunity to tetanus and diphtheria in various age groups of the Polish population. Arch Immunol Ther Exp 1979; 27: 715-726.
15. Ljungman P, Wiklund-Hammarsten M, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496-500.
16. Zander AR, Reuben JM, Johnstone D et al. Immune recovery following allogeneic bone marrow transplantation. Transplantation 1985; 40: 177-183.
17. Hammarström V, Pauksen K, Björkstrand B et al. Tetanus immunity in patients with hematological malignancies and in autologous stem cell transplant (ASCT) recipients. Blood 1995; 86 (Suppl. 1): 105a (Abstr. 408).
18. Hammarström V, Pauksen K, Azinge J et al. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant recipients; the influence of graft versus host reaction. Supp Care Cancer 1993; 1: 195-199.
19. Pauksen K, Hammarström V, Ljungman P et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994; 18: 547-552.
20. Pauksen K, Duraj V, Ljungman P et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427-432.
21. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 377-381.
22. Rosillo MC, Ortuno F, Moraleda JM et al Immune recovery after autologous or rhG-CSF primed PBSC transplantation. Eur J Haematol 1996; 14: 219-223.
23. Simonsson B, Burnett AK, Prentice HG et al. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. Leukemia 1989; 3: 631-636.
24. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulphan and cyclophosphamide regimen. Blood 1987; 8: 1382-1388.
25. Lönnerholm G, Carlsson K, Bratteby LE et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 129-134.
26. Gianni AM, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoetic stem cells for autotransplantation. Lancet 1989; 66: 416-422.
27. Person MAA, Hammarström L, Smith CIE. Enzyme linked immunosorbent assay for subclass distribution IgG and IgA antigen-specific antibodies. J Immunol Meth 1985; 78: 109-115.
28. Simonsen O, Bentzon MW, Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 1986; 14: 231-239.
29. Sedgwick AK, Balow M, Sparks K et al. Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies. J Clin Microbiol 1983; 18: 104-109.
30. Saxon A, Mitsuyasu R, Stevens R et al. Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986; 78: 959-967.
31. Ljungman P, Cordonnier C, De Bock R et al. Immunizations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood an Marrow Transplantation. Bone Marrow Transplant 1995; 15: 455-460.
32. Somani J, Larson RA. Reimmunization after allogeneic bone marrow transplantation. Am J Med 1995; 98: 389-398.
33. Quinti I, Velardi A, Le Moli S et al. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. J Clin Immunol 1990; 10: 160-166.
34. Kishimoto S, Tomino S, Mitsuya H et al. Age-related decline in vitro and in vivo synthesis of anti-tetanus antibodies in humans. J Immunol 1980; 125: 2347-2352.
35. + T-lymphocyte regeneration after intensive chemotherapy. New Eng J Med 1995; 332: 143-149.
36. Lum LG, Burns E, Janson MM et al. IgG anti-tetanus toxoid antibody synthesis by human bone marrow. Two distinct populations of marrow and peripheral blood B cells. J Clin Immunol 1990; 10: 255-264.
37. Opravil M, Matter L, Blaser J et al. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991; 84: 185-189.